首页 › 闭塞性细支气管炎综合征 › 马萨诸塞州 › Boston
Boston MA 闭塞性细支气管炎综合征临床试验
13项针对 闭塞性细支气管炎综合征的研究正在 Boston及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
招募中2 期
- Dana-Farber Cancer Institute, Boston
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
招募中2 期
- Dana-Farber Cancer Institute- Site Number : 8400007, Boston
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
招募中2 期
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
招募中3 期
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
招募中观察性研究
- Massachusetts Cancer Research Center, Boston
Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
招募中1 期
- Dana-Farber Cancer Institute, Boston
Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
招募中观察性研究
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
招募中2 期
- Massachusetts General Hospital, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
招募中2 期
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
招募中3 期
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
招募中
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
招募中2 期
- Dana-Farber Cancer Institute, Boston
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
招募中1 期
- Dana-Farber Cancer Institute, Boston
其他城市的 闭塞性细支气管炎综合征试验
- Seattle, WA11 项研究
- Atlanta, GA10 项研究
- New York City, NY9 项研究
- Houston, TX8 项研究
- Los Angeles, CA7 项研究
- Miami, FL7 项研究
- Baldwin Park, CA6 项研究
- Tampa, FL6 项研究
- Durham, NC6 项研究
- Philadelphia, PA6 项研究
- Washington, DC6 项研究
- San Francisco, CA5 项研究
Boston的其他研究
- 乳腺癌112 项研究
- 非小细胞肺癌90 项研究
- 癌症（所有类型）85 项研究
- 转移性癌症63 项研究
- 结直肠癌63 项研究
- 肺癌62 项研究
- 卵巢癌61 项研究
- 前列腺癌59 项研究
- 抑郁症52 项研究
- 子宫内膜癌50 项研究
- 心力衰竭44 项研究
- 急性髓系白血病44 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。